FeesSafety
Pluang+

REalloys and U.S. Army sign term sheet for heavy rare earth processing facility at Tooele Army Depot

Market News
03 Nov 2026, 16:00 WIB
MCAP MediaWire
View Source
Bullish
REalloys and U.S. Army sign term sheet for heavy rare earth processing facility at Tooele Army Depot

REalloys Inc. and the U.S. Army have executed a non-binding term sheet for a potential long-term lease to develop a heavy rare earth processing facility at Tooele Army Depot, Utah. The facility will process critical minerals like dysprosium and terbium, essential for advanced defense technologies. The lease could last up to 75 years, with REalloys responsible for development, financing, and operation while the Army retains land ownership. Next steps include negotiating a definitive lease and completing regulatory and financing requirements.

The REalloys and U.S. Army rare earth facility deal provides context for readers interested in basic materials. For readers following this sector, here is Pluang's market snapshot as of Nov 03, 2026 20:13 WIB: Of 83 priced Basic Materials-sector US stocks, 25 rose and 55 fell today. Sasol Ltd. (SSL) gained 1.71% to USD 16.08 with a typical hold time of 5 days, Element Solutions Inc. (ESI) rose 1.64% to USD 34.70 with a hold time of 25 days, while Trekor Metals Limited (TGB) declined 1.62% to USD 7.29 with a hold time of 11 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App